BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 36188228)

  • 21. The combination of NDUFS1 with CD4
    Wu D; He L; Xu Z; Tian RF; Fan XY; Fan J; Ai J; Bian HJ; Qin WJ; Qin J; Li L
    Front Cell Dev Biol; 2023; 11():1168462. PubMed ID: 37469574
    [No Abstract]   [Full Text] [Related]  

  • 22. Prognostic Value of Long Noncoding RNA DLEU2 and Its Relationship with Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
    Fu S; Gong B; Wang S; Chen Q; Liu Y; Zhuang C; Li Z; Zhang Z; Ma M; Sun T
    Int J Gen Med; 2021; 14():8047-8064. PubMed ID: 34795513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BAG3 as a novel prognostic biomarker in kidney renal clear cell carcinoma correlating with immune infiltrates.
    Gong B; Huang Y; Wang Z; Wan B; Zeng Y; Lv C
    Eur J Med Res; 2024 Feb; 29(1):93. PubMed ID: 38297320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive Analysis of Glutamate-Rich WD Repeat-Containing Protein 1 and Its Potential Clinical Significance for Pancancer.
    Wu Y; Wu X; Li Y; Zhao W; Yue Y; Wu B; Liu J; Chen X; Shen A
    Biomed Res Int; 2021; 2021():8201377. PubMed ID: 34616846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.
    Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K
    Front Immunol; 2022; 13():903461. PubMed ID: 35663977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction and verification of a novel prognostic risk model for kidney renal clear cell carcinoma based on immunity-related genes.
    Liu Y; Wu D; Chen H; Yan L; Xiang Q; Li Q; Wang T
    Front Genet; 2023; 14():1107294. PubMed ID: 36741315
    [No Abstract]   [Full Text] [Related]  

  • 27. GRAMD1A Is a Biomarker of Kidney Renal Clear Cell Carcinoma and Is Associated with Immune Infiltration in the Tumour Microenvironment.
    Liu Y; Fu S; Zhang Z; Wang S; Cheng X; Li Z; Ding Y; Sun T; Ma M
    Dis Markers; 2022; 2022():5939021. PubMed ID: 35860689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation.
    Zou X; Guo B; Ling Q; Mo Z
    Front Mol Biosci; 2022; 9():832238. PubMed ID: 35127830
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of Cytosolic DNA Sensor cGAS-STING as Immune-Related Risk Factor in Renal Carcinoma following Pan-Cancer Analysis.
    Wu Z; Lin Y; Liu LM; Hou YL; Qin WT; Zhang L; Jiang SH; Yang Q; Bai YR
    J Immunol Res; 2022; 2022():7978042. PubMed ID: 35983076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comprehensive analysis of essential meiotic endonuclease 1 to prognosis and immune infiltration in kidney renal clear cell carcinoma.
    Li HD; Ma HX; Ma JH; Kong SP; Zhao ST; Fan SQ; Qin F; Ma JG
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):584-602. PubMed ID: 38305603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-omics Analysis of Prognostic Significance and Immune Infiltration of FASTK Family Members in Kidney Renal Clear Cell Carcinoma.
    Zhong G; Wu D; Chen H; Yan L; Xiang Q; Liu Y; Wang T
    Evol Bioinform Online; 2023; 19():11769343231212078. PubMed ID: 38033663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
    Jiang H; Chen H; Wan P; Chen N
    Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
    Cheng L; Mi J; Zhang J; Huang H; Mo Z
    Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioinformatic analyses reveal the prognostic significance and potential role of ankyrin 3 (ANK3) in kidney renal clear cell carcinoma.
    Somsuan K; Aluksanasuwan S
    Genomics Inform; 2023 Jun; 21(2):e22. PubMed ID: 37423640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The roles and potential mechanisms of HCST in the prognosis and immunity of KIRC via comprehensive analysis.
    Wang W; Li S; Lin J; Guo X; Xie Y; Li W; Hao Y; Jiang X
    Am J Transl Res; 2022; 14(2):752-771. PubMed ID: 35273683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudogene HSPA7 is a poor prognostic biomarker in Kidney Renal Clear Cell Carcinoma (KIRC) and correlated with immune infiltrates.
    Ding C; He R; Zhang J; Dong Z; Wu J
    Cancer Cell Int; 2021 Aug; 21(1):435. PubMed ID: 34412642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
    Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.
    Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674
    [No Abstract]   [Full Text] [Related]  

  • 39. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma.
    Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D
    Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and prognosis analysis of PAQR5 in kidney cancer.
    Lu T; Xu HR; Dong W; Dong H
    Front Oncol; 2022; 12():955510. PubMed ID: 36119517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.